Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 13 studies | 36% ± 15% | |
type II pneumocyte | 6 studies | 23% ± 7% | |
cardiac muscle cell | 5 studies | 31% ± 4% | |
glutamatergic neuron | 4 studies | 52% ± 7% | |
oligodendrocyte precursor cell | 4 studies | 26% ± 7% | |
basal cell | 4 studies | 29% ± 15% | |
epithelial cell | 3 studies | 39% ± 20% | |
GABAergic neuron | 3 studies | 32% ± 11% | |
keratinocyte | 3 studies | 30% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 27% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 4585.50 | 649 / 653 | 86% | 156.69 | 519 / 605 |
lung | 54% | 674.84 | 310 / 578 | 71% | 46.28 | 815 / 1155 |
kidney | 47% | 411.54 | 42 / 89 | 62% | 29.90 | 561 / 901 |
esophagus | 38% | 614.51 | 546 / 1445 | 68% | 50.79 | 124 / 183 |
skin | 72% | 6304.37 | 1302 / 1809 | 27% | 8.63 | 127 / 472 |
muscle | 98% | 2600.90 | 788 / 803 | 0% | 0 | 0 / 0 |
brain | 43% | 460.79 | 1135 / 2642 | 53% | 11.91 | 372 / 705 |
heart | 95% | 4572.87 | 818 / 861 | 0% | 0 | 0 / 0 |
intestine | 28% | 499.56 | 271 / 966 | 65% | 24.43 | 341 / 527 |
tonsil | 0% | 0 | 0 / 0 | 80% | 72.19 | 36 / 45 |
uterus | 2% | 55.93 | 4 / 170 | 73% | 43.53 | 337 / 459 |
pancreas | 0% | 1.96 | 1 / 328 | 64% | 18.06 | 114 / 178 |
ovary | 0% | 0 | 0 / 180 | 60% | 16.15 | 260 / 430 |
bladder | 0% | 0 | 0 / 21 | 51% | 24.60 | 256 / 504 |
stomach | 0% | 0 | 0 / 359 | 43% | 19.49 | 123 / 286 |
breast | 8% | 65.39 | 38 / 459 | 22% | 13.55 | 247 / 1118 |
liver | 0% | 0 | 0 / 226 | 6% | 3.19 | 26 / 406 |
adrenal gland | 0% | 0 | 0 / 258 | 5% | 1.44 | 11 / 230 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.48 | 1 / 29 |
prostate | 1% | 7.73 | 3 / 245 | 1% | 0.15 | 6 / 502 |
blood vessel | 2% | 26.13 | 29 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.13 | 1 / 80 |
adipose | 0% | 7.95 | 4 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042325 | Biological process | regulation of phosphorylation |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0004865 | Molecular function | protein serine/threonine phosphatase inhibitor activity |
Gene name | PPP1R14C |
Protein name | Alternative protein PPP1R14C Protein phosphatase 1 regulatory subunit 14C (Kinase-enhanced PP1 inhibitor) (PKC-potentiated PP1 inhibitory protein) (Serologically defined breast cancer antigen NY-BR-81) |
Synonyms | KEPI |
Description | FUNCTION: Inhibitor of the PP1 regulatory subunit PPP1CA. |
Accessions | Q8TAE6 ENST00000361131.5 L8EAF9 |